Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Osteoclast differentiation	17/127	1.8256241241499607E-8	5.622922302381879E-6	0	0	5.365060830322062	95.59872504135342	LILRA6;CSF1R;SPI1;NCF1;LILRB1;LILRA1;LILRB2;LILRA2;LILRB3;LILRA3;SIRPB1;OSCAR;LILRA5;BTK;FCGR2B;MAP2K6;MAPK3
Hematopoietic cell lineage	11/97	3.004667225987695E-5	0.00462718752802105	0	0	4.545172819866537	47.327787564989926	CSF1R;IL11;HLA-DMA;CD4;CR1;ITGA2;CD59;CD1D;CD36;CD1C;CD33
Longevity regulating pathway	10/102	2.338268427924524E-4	0.02400622252669178	0	0	3.929427482415812	32.85366695979931	SESN3;RPS6KB1;HSPA6;BAX;HSPA2;PRKACA;SIRT1;HSPA1B;CREB5;HSPA1A
Prion diseases	5/35	0.0016576540351121863	0.12763936070363835	0	0	5.72573718866304	36.658184414702575	PRNP;BAX;PRKACA;MAPK3;HSPA1A
Legionellosis	6/55	0.0024105727038740256	0.14849127855863997	0	0	4.37238112588814	26.35623650172371	CR1;HSPA6;HSPA2;HSPA1B;HSPD1;HSPA1A
Glycolysis / Gluconeogenesis	6/68	0.006943799841148308	0.35644839184561317	0	0	3.536484734174231	17.575997147562024	HK3;ALDH2;ALDH3B1;PGAM4;BPGM;FBP1
Malaria	5/49	0.007324473061140072	0.32227681469016317	0	0	4.089812277616457	20.107701377090194	CR1;LRP1;HGF;CD36;MET
Toxoplasmosis	8/113	0.007407615013753291	0.2851931780295017	0	0	2.837533474027701	13.918801857093245	HLA-DMA;ALOX5;HSPA6;HSPA2;HSPA1B;MAP2K6;MAPK3;HSPA1A
Fc gamma R-mediated phagocytosis	7/91	0.007712307108642946	0.26393228771800303	0	0	3.083089255433945	14.999037768731213	MARCKSL1;GSN;NCF1;RPS6KB1;WAS;FCGR2B;MAPK3
Cholesterol metabolism	5/50	0.007975304632425061	0.24563938267869187	0	0	4.008016032064129	19.364350431332927	LRP1;OSBPL5;SORT1;VDAC1;CD36
Protein processing in endoplasmic reticulum	10/165	0.008592217083715305	0.24058207834402853	0	0	2.4291006254934113	11.55498506282689	GANAB;HSPH1;HSPA6;BAX;CAPN1;HSPA2;BAK1;RNF185;HSPA1B;HSPA1A
Hepatocellular carcinoma	10/168	0.009687332341123575	0.24864153008883846	0	0	2.3857238286096	11.062449163028825	FZD2;SMARCD3;RPS6KB1;HGF;FZD7;TXNRD1;BAX;BAK1;MET;MAPK3
Antigen processing and presentation	6/77	0.012486189128280962	0.2958266347315797	0	0	3.1231293756343854	13.689088666361078	HLA-DMA;CD4;HSPA6;HSPA2;HSPA1B;HSPA1A
Complement and coagulation cascades	6/79	0.01404703110254987	0.30903468425609715	0	0	3.044062809162629	12.9839756930319	CR1;SERPINB2;C1R;SERPING1;CD59;VSIG4
Phagosome	9/152	0.014193490684288426	0.2914396753840557	0	0	2.3731673874063914	10.097760362275961	MARCO;HLA-DMA;NCF1;CLEC7A;C1R;ITGA2;CD36;FCGR2B;ATP6V1D
MAPK signaling pathway	14/295	0.01668439304221184	0.32117456606257794	0	0	1.9021093033524676	7.785868907781114	CSF1R;HGF;HSPA6;CACNA2D3;ARRB1;HSPA2;DUSP10;RRAS;PRKACA;MET;HSPA1B;HSPA1A;MAP2K6;MAPK3
Histidine metabolism	3/23	0.01886853485257483	0.3418534549760616	0	0	5.227846998344515	20.755909559408284	ALDH2;ALDH3B1;HNMT
TGF-beta signaling pathway	6/90	0.025100618407112498	0.42949947052170273	0	0	2.6720106880427523	9.845992773318203	TGIF1;PPP2CB;TGIF2;RPS6KB1;ID3;MAPK3
Staphylococcus aureus infection	5/68	0.027329937014096112	0.44303266317587375	0	0	2.947070611811859	10.608783990593563	HLA-DMA;C1R;FPR1;FPR2;FCGR2B
Influenza A	9/171	0.028024886555337702	0.4315832529522006	0	0	2.1094821221390148	7.540686336911549	HLA-DMA;HSPA6;VDAC1;HSPA2;HSPA1B;MAP2K6;SLC25A6;MAPK3;HSPA1A
Gastric cancer	8/149	0.03355551798851071	0.49214759716482376	0	0	2.1519549165444984	7.3049270804520345	FZD2;RPS6KB1;HGF;FZD7;BAX;BAK1;MET;MAPK3
Melanoma	5/72	0.033872830469891285	0.47421962657847794	0	0	2.7833444667112004	9.42201638555587	HGF;BAX;BAK1;MET;MAPK3
Leishmaniasis	5/74	0.03747853104420887	0.5018864157224492	0	0	2.7081189405838706	8.89342743713746	HLA-DMA;MARCKSL1;CR1;NCF1;MAPK3
Ribosome biogenesis in eukaryotes	6/101	0.04082191477626721	0.5238812396287625	0	0	2.380999623008393	7.615713521864473	RBM28;WDR3;AK6;REXO2;RPP38;GNL3
Glucagon signaling pathway	6/103	0.04422228412323768	0.5448185403982881	0	0	2.3347666206198805	7.281031463929472	PGAM4;PYGL;PRKACA;SIRT1;FBP1;CREB5
Human T-cell leukemia virus 1 infection	10/219	0.04871446534551358	0.5770790510160839	0	0	1.8301443068785972	5.530292115401894	HLA-DMA;CD4;SPI1;BAX;VDAC1;LTBR;PRKACA;CREB5;SLC25A6;MAPK3
Insulin resistance	6/108	0.053478633995713745	0.6100525655807346	0	0	2.22667557336896	6.520759450931955	RPS6KB1;PYGL;CD36;SLC27A3;SLC27A2;CREB5
Estrogen signaling pathway	7/137	0.05616179961594165	0.6177797957753581	0	0	2.0478914032444453	5.896941131121255	HSPA6;HSPA2;PRKACA;HSPA1B;CREB5;MAPK3;HSPA1A
Insulin signaling pathway	7/137	0.05616179961594165	0.5964770441968975	0	0	2.0478914032444453	5.896941131121255	HK3;RPS6KB1;PYGL;PRKACA;FBP1;SH2B2;MAPK3
Measles	7/138	0.05795708301686029	0.5950260523064322	0	0	2.0330516104673118	5.790237702135466	HSPA6;BAX;HSPA2;BAK1;FCGR2B;HSPA1B;HSPA1A
Cholinergic synapse	6/112	0.06166951394784325	0.6127164611592169	0	0	2.14715144574864	5.981890004674994	GNG4;KCNQ1;CHRNA6;PRKACA;CREB5;MAPK3
Primary immunodeficiency	3/37	0.06422834016420031	0.6181977740804281	0	0	3.2497427287006446	8.921553583201426	CD4;BTK;ADA
Thyroid cancer	3/37	0.06422834016420031	0.5994645081992029	0	0	3.2497427287006446	8.921553583201426	BAX;BAK1;MAPK3
Proteoglycans in cancer	9/201	0.06561079446997596	0.5943566087280175	0	0	1.7946340442078186	4.8886101397811865	FZD2;RRAS;RPS6KB1;FZD7;HGF;ITGA2;PRKACA;MET;MAPK3
Adrenergic signaling in cardiomyocytes	7/145	0.07151045580415501	0.6292920110765641	0	0	1.9349042913413033	5.104106484597413	PPP2CB;KCNQ1;CACNA2D3;PRKACA;SLC8A1;CREB5;MAPK3
Basal cell carcinoma	4/63	0.07223918589006367	0.6180463681705448	0	0	2.54477208385024	6.687082455588763	FZD2;FZD7;BAX;BAK1
Dilated cardiomyopathy (DCM)	5/91	0.077374648832407	0.6440916713616582	0	0	2.202206611024246	5.635658319942324	ITGA2;LMNA;CACNA2D3;PRKACA;SLC8A1
Ferroptosis	3/40	0.07739908621583053	0.6273399619598896	0	0	3.006012024048096	7.691724362083672	PRNP;SLC7A11;GCLM
Central carbon metabolism in cancer	4/65	0.0790619269598124	0.6243865000928774	0	0	2.466471404347156	6.258730009004337	HK3;PGAM4;MET;MAPK3
AMPK signaling pathway	6/120	0.08015643255914096	0.6172045307053853	0	0	2.0040080160320644	5.057665624526348	PPP2CB;RPS6KB1;CD36;SIRT1;FBP1;CREB5
Tuberculosis	8/179	0.08030941234379416	0.6032999756558195	0	0	1.7912920813694428	4.517402985020568	HLA-DMA;CR1;CLEC7A;CARD9;BAX;FCGR2B;HSPD1;MAPK3
Bladder cancer	3/41	0.08203209740102893	0.6015687142742122	0	0	2.9326946576078985	7.333627283603584	RASSF1;UPK3A;MAPK3
Acute myeloid leukemia	4/66	0.08258943168134009	0.5915708129733197	0	0	2.4291006254934113	6.057869806005826	CSF1R;SPI1;RPS6KB1;MAPK3
Non-small cell lung cancer	4/66	0.08258943168134009	0.5781260217693807	0	0	2.4291006254934113	6.057869806005826	RASSF1;BAX;BAK1;MAPK3
Human immunodeficiency virus 1 infection	9/212	0.08489892959522476	0.5810860070073162	0	0	1.7015162400272241	4.196438942445212	BST2;CD4;RPS6KB1;GNG4;BAX;BAK1;APOBEC3A;MAP2K6;MAPK3
Fc epsilon RI signaling pathway	4/68	0.08987210021782867	0.6017523231976354	0	0	2.357656489449487	5.680461459566916	ALOX5;BTK;MAPK3;MAP2K6
Platelet activation	6/124	0.09044358657766254	0.5926941418280864	0	0	1.939362596160062	4.6603445123298695	ITGA2;P2RX1;TBXAS1;BTK;PRKACA;MAPK3
B cell receptor signaling pathway	4/71	0.10134994662155618	0.6503288241549855	0	0	2.2580372011628893	5.169044416175678	BTK;LILRB3;FCGR2B;MAPK3
Choline metabolism in cancer	5/99	0.10180249347524367	0.6399013875586745	0	0	2.024250521244509	4.624847030025263	CHKB;RPS6KB1;WAS;DGKZ;MAPK3
Chemokine signaling pathway	8/190	0.1040276183991464	0.6408101293387418	0	0	1.6875856977112118	3.8191732577841697	GSK3A;NCF1;CCL7;GNG4;WAS;ARRB1;PRKACA;MAPK3
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	4/72	0.10531919102099033	0.6360453104797062	0	0	2.22667557336896	5.011711479706742	ITGA2;LMNA;CACNA2D3;SLC8A1
Cellular senescence	7/160	0.10635564067695515	0.6299526409327344	0	0	1.753507014028056	3.9295508265428185	RRAS;VDAC1;CAPN1;SIRT1;MAP2K6;SLC25A6;MAPK3
Hippo signaling pathway	7/160	0.10635564067695515	0.6180667420472111	0	0	1.753507014028056	3.9295508265428185	PPP2CB;RASSF1;FZD2;RASSF4;FZD7;TP53BP2;NKD1
Mismatch repair	2/23	0.11150273046053624	0.6359785367008364	0	0	3.485231332229677	7.6455735817600345	PCNA;RPA3
Thyroid hormone synthesis	4/74	0.11346553890858065	0.6354070178880517	0	0	2.1664951524670966	4.714848313088854	PRKACA;ASGR1;ASGR2;CREB5
Glioma	4/75	0.11764015216281094	0.6470208368954602	0	0	2.137608550434202	4.574749225032847	BAX;BAK1;CAMK1;MAPK3
Pancreatic cancer	4/75	0.11764015216281094	0.6356695941429082	0	0	2.137608550434202	4.574749225032847	RPS6KB1;BAX;BAK1;MAPK3
Neomycin, kanamycin and gentamicin biosynthesis	1/5	0.11868930417379521	0.6302811325091194	0	0	8.016032064128257	17.084136989836733	HK3
Spliceosome	6/134	0.11910729205838158	0.621780439897992	0	0	1.7946340442078186	3.8184977324397953	PRPF4;HSPA6;HSPA2;USP39;HSPA1B;HSPA1A
Arginine and proline metabolism	3/49	0.12303208395108468	0.631564697615568	0	0	2.4538873665698744	5.141655014092984	ALDH4A1;ARG2;ALDH2
Apelin signaling pathway	6/137	0.12849397204041735	0.6487892358762056	0	0	1.7553354884952388	3.6017259967031605	RRAS;RPS6KB1;GNG4;PRKACA;SLC8A1;MAPK3
Vibrio cholerae infection	3/50	0.128601317189854	0.6388581563625004	0	0	2.4048096192384767	4.932356452177673	KCNQ1;PRKACA;ATP6V1D
Biosynthesis of unsaturated fatty acids	2/27	0.1451644549749239	0.7096928909885167	0	0	2.9689007644919467	5.72964597939032	FADS2;FADS1
Breast cancer	6/147	0.16220880408013091	0.78062986963563	0	0	1.6359249110465828	2.9755361492152446	FZD2;RPS6KB1;FZD7;BAX;BAK1;MAPK3
Hypertrophic cardiomyopathy (HCM)	4/85	0.16278432837254328	0.7713472790575897	0	0	1.8861251915595898	3.423937933495602	ITGA2;LMNA;CACNA2D3;SLC8A1
Colorectal cancer	4/86	0.16760707324407684	0.7821663418056919	0	0	1.864193503285641	3.3296973271151256	RPS6KB1;BAX;BAK1;MAPK3
Axon guidance	7/181	0.1676765756704027	0.770811720992299	0	0	1.5500614488645799	2.7679730951619574	EFNB2;NTNG2;RRAS;FES;PLXNB2;MET;MAPK3
Nicotinate and nicotinamide metabolism	2/30	0.17159496050911424	0.7772242328942234	0	0	2.6720106880427523	4.709735364120289	BST1;PNP
Pentose phosphate pathway	2/30	0.17159496050911424	0.7659601135769158	0	0	2.6720106880427523	4.709735364120289	H6PD;FBP1
Endometrial cancer	3/58	0.17603867561833744	0.7745701727206847	0	0	2.073111740722825	3.6011019838025167	BAX;BAK1;MAPK3
Galactose metabolism	2/31	0.18057393039320113	0.7833347966352951	0	0	2.5858167948800825	4.425922809233922	HK3;GLA
beta-Alanine metabolism	2/31	0.18057393039320113	0.7724551466820271	0	0	2.5858167948800825	4.425922809233922	ALDH2;ALDH3B1
Calcium signaling pathway	7/188	0.19098745825328053	0.805810097835759	0	0	1.4923463949174944	2.4706503681422243	HRH2;P2RX1;VDAC1;CAMK1;PRKACA;SLC8A1;SLC25A6
Rheumatoid arthritis	4/91	0.19244164904232453	0.8009733500680535	0	0	1.761765288819397	2.9033227652017337	IL11;HLA-DMA;LTB;ATP6V1D
Glycerolipid metabolism	3/61	0.1949325740274965	0.8005231040062523	0	0	1.971155425605309	3.2230393004304587	ALDH2;DGKZ;GLA
Fructose and mannose metabolism	2/33	0.19872802219851757	0.8053714583834659	0	0	2.4291006254934113	3.924984785802817	HK3;FBP1
Human cytomegalovirus infection	8/225	0.20149963976428117	0.8059985590571247	0	0	1.4250723669561345	2.2829198811736386	RPS6KB1;GNG4;BAX;BAK1;PRKACA;MAP2K6;CREB5;MAPK3
Human papillomavirus infection	11/330	0.20401455401054247	0.8055959312211164	0	0	1.3360053440213762	2.1236659245074034	PPP2CB;FZD2;RPS6KB1;FZD7;ITGA2;BAX;BAK1;PRKACA;ATP6V1D;CREB5;MAPK3
Autophagy	5/128	0.21593526027756207	0.8418741793099888	0	0	1.5656312625250501	2.3997630216064656	PPP2CB;RRAS;RPS6KB1;PRKACA;MAPK3
Necroptosis	6/162	0.218881841452802	0.8426950895932878	0	0	1.4844503822459734	2.255211506736668	ZBP1;BAX;VDAC1;CAPN1;PYGL;SLC25A6
Ras signaling pathway	8/232	0.2244272468579372	0.8533776794104279	0	0	1.3820744938152165	2.06510081095843	CSF1R;RASSF1;RRAS;GNG4;HGF;PRKACA;MET;MAPK3
Relaxin signaling pathway	5/130	0.22496994660897685	0.8450090677507911	0	0	1.5415446277169724	2.2996584805392892	GNG4;ARRB1;PRKACA;CREB5;MAPK3
DNA replication	2/36	0.22632085176125513	0.839841233041766	0	0	2.22667557336896	3.308398103918243	PCNA;RPA3
Starch and sucrose metabolism	2/36	0.22632085176125513	0.8298431231246022	0	0	2.22667557336896	3.308398103918243	HK3;PYGL
Dopaminergic synapse	5/131	0.22952919490766185	0.8317057886065865	0	0	1.5297771114748582	2.2514112907425994	PPP2CB;GSK3A;GNG4;PRKACA;CREB5
Viral carcinogenesis	7/201	0.2374035027968392	0.8502358007142613	0	0	1.3958264788283035	2.0071901603390128	GSN;BAX;BAK1;LTBR;PRKACA;CREB5;MAPK3
HIF-1 signaling pathway	4/100	0.23968338581685691	0.8485342854205968	0	0	1.6032064128256514	2.290078480717619	HK3;RPS6KB1;LTBR;MAPK3
Amphetamine addiction	3/68	0.24069522750495437	0.8424332962673403	0	0	1.7682423670871155	2.518372796101562	PRKACA;SIRT1;CREB5
Taurine and hypotaurine metabolism	1/11	0.24270438526211566	0.8399207939408048	0	0	3.6436509382401168	5.159085799816664	GGT7
Melanogenesis	4/101	0.24509524373944783	0.8387703896861104	0	0	1.5873330820055953	2.231962370720319	FZD2;FZD7;PRKACA;MAPK3
Renal cell carcinoma	3/69	0.24738022597343726	0.837286918679326	0	0	1.7426156661148384	2.4341356618782064	HGF;MET;MAPK3
Tight junction	6/170	0.25150624808965866	0.8419991783871181	0	0	1.4145938936696922	1.9525461932600603	PPP2CB;PCNA;WAS;CD1D;PRKACA;CD1C
Rap1 signaling pathway	7/206	0.2561690421193254	0.8483877954059378	0	0	1.361947195361597	1.8548600349200546	CSF1R;RRAS;HGF;FPR1;MET;MAP2K6;MAPK3
C-type lectin receptor signaling pathway	4/104	0.261486324140045	0.8567849769695093	0	0	1.5415446277169724	2.0677867960356835	RRAS;CLEC7A;CARD9;MAPK3
Glycine, serine and threonine metabolism	2/40	0.26346556444202246	0.8541830931383464	0	0	2.0040080160320644	2.6730112320046	PGAM4;BPGM
Signaling pathways regulating pluripotency of stem cells	5/139	0.26688352910714297	0.8562513225520837	0	0	1.4417323856345785	1.904446210876801	FZD2;FZD7;ID3;SKIL;MAPK3
Adherens junction	3/72	0.26759356518056165	0.8496785368619896	0	0	1.67000668002672	2.2015464218898466	WAS;MET;MAPK3
Parathyroid hormone synthesis, secretion and action	4/106	0.27252830085351726	0.856517516968197	0	0	1.5124588800241994	1.9662159245711834	ARRB1;PRKACA;CREB5;MAPK3
Th17 cell differentiation	4/107	0.2780792262008715	0.8651353704027113	0	0	1.498323750304347	1.917628482472716	HLA-DMA;CD4;IRF4;MAPK3
PPAR signaling pathway	3/74	0.28117407837650027	0.8660161613996209	0	0	1.6248713643503223	2.0616064108569248	FADS2;CD36;SLC27A2
Apoptosis	5/143	0.286048958431383	0.8723077148204551	0	0	1.4014042070154296	1.7539867139677459	LMNA;BAX;CAPN1;BAK1;MAPK3
Gastric acid secretion	3/75	0.2879879916633639	0.86961079835604	0	0	1.6032064128256514	1.9957298522305367	HRH2;KCNQ1;PRKACA
Type I diabetes mellitus	2/43	0.29135825394517834	0.8712460409234459	0	0	1.864193503285641	2.2989265149749634	HLA-DMA;HSPD1
Chronic myeloid leukemia	3/76	0.29481431932337215	0.8731039456884483	0	0	1.582111591604261	1.9324062021461406	BAX;BAK1;MAPK3
Pertussis	3/76	0.29481431932337215	0.864788670015225	0	0	1.582111591604261	1.9324062021461406	C1R;SERPING1;MAPK3
Cell adhesion molecules (CAMs)	5/145	0.29572740502498984	0.8592834032801592	0	0	1.3820744938152165	1.6838050970123954	SPN;NTNG2;HLA-DMA;CD4;CD99
Vasopressin-regulated water reabsorption	2/44	0.3006315833357493	0.8653694174524372	0	0	1.8218254691200584	2.1895969020440007	PRKACA;CREB5
Glycosphingolipid biosynthesis	2/45	0.30988425031274364	0.8837439731141208	0	0	1.7813404586951682	2.0869408814372057	FUT7;GLA
Serotonergic synapse	4/113	0.311713181627131	0.8808042196436362	0	0	1.4187667370138506	1.6538163812725102	GNG4;ALOX5;PRKACA;MAPK3
Cytokine-cytokine receptor interaction	9/294	0.3136938645164677	0.8783428206461095	0	0	1.2269436832849372	1.422442095316743	IL11;CSF1R;CD4;CCL7;TNFSF12;TNFRSF10C;IL36G;LTB;LTBR
Type II diabetes mellitus	2/46	0.31911152054298275	0.8854625975426909	0	0	1.7426156661148384	1.990441131153559	HK3;MAPK3
Transcriptional misregulation in cancer	6/186	0.32015621613151757	0.8804295943616733	0	0	1.2929083974400413	1.472553140986777	CSF1R;SPI1;LMO2;BAX;BAK1;MET
Hedgehog signaling pathway	2/47	0.3283089077825412	0.8948596778497583	0	0	1.705538737048565	1.8996295941430157	ARRB1;PRKACA
Nucleotide excision repair	2/47	0.3283089077825412	0.8870100315528305	0	0	1.705538737048565	1.8996295941430157	PCNA;RPA3
mTOR signaling pathway	5/152	0.32997914748241675	0.8837702384746466	0	0	1.3184263263368843	1.4617733044580876	FZD2;RPS6KB1;FZD7;ATP6V1D;MAPK3
Amino sugar and nucleotide sugar metabolism	2/48	0.33747216444826783	0.8960467814660904	0	0	1.67000668002672	1.814081910119734	HK3;PGM3
Endocrine and other factor-regulated calcium reabsorption	2/48	0.33747216444826783	0.8883882619663802	0	0	1.67000668002672	1.814081910119734	PRKACA;SLC8A1
Intestinal immune network for IgA production	2/48	0.33747216444826783	0.8808595478819194	0	0	1.67000668002672	1.814081910119734	HLA-DMA;LTBR
Cushing syndrome	5/155	0.3447844025119361	0.8923831594426582	0	0	1.2929083974400413	1.37673537727078	FZD2;FZD7;PRKACA;CREB5;MAPK3
Pathways in cancer	15/530	0.34569412033484814	0.8872815755261102	0	0	1.1343441600181496	1.2049014332792751	CSF1R;SPI1;FZD2;FZD7;ITGA2;TXNRD1;HGF;RASSF1;RPS6KB1;GNG4;BAX;BAK1;PRKACA;MET;MAPK3
Neurotrophin signaling pathway	4/119	0.34569465792038206	0.8799500383427907	0	0	1.3472322796854213	1.4310292990807465	SORT1;BAX;SH2B2;MAPK3
Sphingolipid signaling pathway	4/119	0.34569465792038206	0.8727373331104729	0	0	1.3472322796854213	1.4310292990807465	PPP2CB;S1PR1;BAX;MAPK3
Cocaine addiction	2/49	0.3465972728961172	0.8679021142439357	0	0	1.6359249110465828	1.7334125719038218	PRKACA;CREB5
Ovarian steroidogenesis	2/49	0.3465972728961172	0.8609029036451943	0	0	1.6359249110465828	1.7334125719038218	ALOX5;PRKACA
Phenylalanine metabolism	1/17	0.3492984738086775	0.8606714394645814	0	0	2.357656489449487	2.4798502804764877	ALDH3B1
Selenocompound metabolism	1/17	0.3492984738086775	0.853840713754545	0	0	2.357656489449487	2.4798502804764877	TXNRD1
Salmonella infection	3/86	0.3632482347064938	0.8809484747212606	0	0	1.3981451274642307	1.4158579991575921	WAS;PKN1;MAPK3
Amyotrophic lateral sclerosis (ALS)	2/51	0.3647180697747147	0.8776028553954073	0	0	1.5717709929663248	1.585336375400671	BAX;MAP2K6
Pantothenate and CoA biosynthesis	1/19	0.38139108902006696	0.9106081815362839	0	0	2.1094821221390148	2.033392996431885	AASDHPPT
Steroid biosynthesis	1/19	0.38139108902006696	0.9036035032167741	0	0	2.1094821221390148	2.033392996431885	SC5D
Hepatitis B	5/163	0.38440843079655873	0.9037999746972526	0	0	1.2294527705718186	1.1754179153071047	PCNA;BAX;MAP2K6;CREB5;MAPK3
PI3K-Akt signaling pathway	10/354	0.38998529926603265	0.9099656982874096	0	0	1.1322079186621832	1.0661393235720578	PPP2CB;CSF1R;RPS6KB1;GNG4;HGF;ITGA2;PKN1;MET;CREB5;MAPK3
Protein digestion and absorption	3/90	0.3904133844435715	0.9041152060798497	0	0	1.3360053440213762	1.2565786788347324	KCNQ1;SLC16A10;SLC8A1
Morphine addiction	3/91	0.3971624190671116	0.9128807841244057	0	0	1.3213239666145478	1.220123718983501	GNG4;ARRB1;PRKACA
cGMP-PKG signaling pathway	5/166	0.39925885939412553	0.910901694025116	0	0	1.2072337445976289	1.1084159910682518	VDAC1;SLC8A1;CREB5;SLC25A6;MAPK3
Th1 and Th2 cell differentiation	3/92	0.4038911977921537	0.9146947714704657	0	0	1.3069617495861288	1.184904264643733	HLA-DMA;CD4;MAPK3
Endocytosis	7/244	0.40802732385551116	0.9173169032664047	0	0	1.1498406649364303	1.0307414757554452	HSPA6;WAS;ARRB1;HSPA2;FOLR2;HSPA1B;HSPA1A
Glutathione metabolism	2/56	0.40911169681555504	0.9130898740521083	0	0	1.43143429716576	1.2793688274765	GGT7;GCLM
GnRH signaling pathway	3/93	0.4105981346365888	0.9098145717127291	0	0	1.2929083974400413	1.1508698913002264	PRKACA;MAPK3;MAP2K6
Small cell lung cancer	3/93	0.4105981346365888	0.9033158962004953	0	0	1.2929083974400413	1.1508698913002264	ITGA2;BAX;BAK1
Arginine biosynthesis	1/21	0.41190390766271523	0.8997617273767113	0	0	1.90857906288768	1.6928431924118923	ARG2
Pyrimidine metabolism	2/57	0.41781177566433786	0.9062396260888455	0	0	1.4063214147593432	1.2273307953808836	CDA;PNP
FoxO signaling pathway	4/132	0.4192144682364564	0.9029234700477522	0	0	1.2145503127467057	1.0558968028761182	CDKN2D;S1PR1;SIRT1;MAPK3
NF-kappa B signaling pathway	3/95	0.4239403945022609	0.906761399352058	0	0	1.2656892732834089	1.0861669604089468	BTK;LTB;LTBR
Amoebiasis	3/96	0.4305727998658044	0.9145960162666742	0	0	1.25250501002004	1.055409398837322	ARG2;CD1D;PRKACA
Lysine degradation	2/59	0.43501379097770626	0.9177003261721475	0	0	1.3586495023946197	1.1309093373173045	ALDH2;EZH2
Circadian entrainment	3/97	0.43717752665197956	0.9159910082231952	0	0	1.2395925872363285	1.0256586495480642	GNG4;PRKACA;MAPK3
Long-term depression	2/60	0.44351155902623823	0.9229835147302796	0	0	1.3360053440213762	1.0862143144673617	PPP2CB;MAPK3
Aldosterone synthesis and secretion	3/98	0.44375323966298486	0.9172885759476465	0	0	1.2269436832849372	0.9968753477201518	CAMK1;PRKACA;CREB5
Pancreatic secretion	3/98	0.44375323966298486	0.9111733187746622	0	0	1.2269436832849372	0.9968753477201518	BST1;RAB3D;KCNQ1
Alcoholism	5/180	0.46776769301556015	0.9541221817800829	0	0	1.11333778668448	0.8458956677225836	GNG4;PKIA;PRKACA;CREB5;MAPK3
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/25	0.4684968242387519	0.9493225122732604	0	0	1.6032064128256514	1.2155927148684615	PGAP1
alpha-Linolenic acid metabolism	1/25	0.4684968242387519	0.9431177899708209	0	0	1.6032064128256514	1.2155927148684615	FADS2
Arachidonic acid metabolism	2/63	0.4685698743106791	0.9371397486213582	0	0	1.27238604192512	0.9645577423859204	ALOX5;TBXAS1
Neuroactive ligand-receptor interaction	9/338	0.46891477212383276	0.9317790310589709	0	0	1.0672232038040579	0.808244684208509	P2RY13;NMB;HRH2;P2RX1;CHRNA6;FPR1;S1PR1;NMUR1;FPR2
Parkinson disease	4/142	0.47446427722194295	0.9367628037458874	0	0	1.1290186005814447	0.8417612112814139	LRRK2;VDAC1;PRKACA;SLC25A6
Toll-like receptor signaling pathway	3/104	0.4825294405050263	0.9466182654493508	0	0	1.1561584707877293	0.8425081048332875	TLR8;MAP2K6;MAPK3
Cortisol synthesis and secretion	2/65	0.4848972014536226	0.9452426458716187	0	0	1.233235702173578	0.8926386511807349	PRKACA;CREB5
Shigellosis	2/65	0.4848972014536226	0.9392977235705393	0	0	1.233235702173578	0.8926386511807349	WAS;MAPK3
Aminoacyl-tRNA biosynthesis	2/66	0.4929433227493972	0.9489158962925895	0	0	1.2145503127467057	0.8591256155286086	TARS;HARS2
Ascorbate and aldarate metabolism	1/27	0.49472092704616494	0.9464226430448374	0	0	1.4844503822459734	1.0446989670368623	ALDH2
Collecting duct acid secretion	1/27	0.49472092704616494	0.9405805279643137	0	0	1.4844503822459734	1.0446989670368623	ATP6V1D
Kaposi sarcoma-associated herpesvirus infection	5/186	0.4964293760649176	0.9380383302330959	0	0	1.077423664533368	0.7545349292021438	GNG4;BAX;BAK1;MAP2K6;MAPK3
Long-term potentiation	2/67	0.500909536056892	0.9407325433263583	0	0	1.1964226961385458	0.8271226165215465	PRKACA;MAPK3
Epithelial cell signaling in Helicobacter pylori infection	2/68	0.5087948142513435	0.9497503199358414	0	0	1.1788282447247436	0.7965465744715722	MET;ATP6V1D
TNF signaling pathway	3/110	0.519976372135044	0.9647754374553829	0	0	1.093095281472035	0.714853605364382	MAP2K6;CREB5;MAPK3
Huntington disease	5/193	0.5291071999108136	0.9758384285780274	0	0	1.0383461222964063	0.6609739907998292	POLR2D;BAX;VDAC1;CREB5;SLC25A6
Citrate cycle (TCA cycle)	1/30	0.531655622454183	0.9747019744993354	0	0	1.3360053440213762	0.8440338349505794	SUCLA2
Oxytocin signaling pathway	4/153	0.532791765170768	0.9710051104887369	0	0	1.0478473286442165	0.6597504715427924	CACNA2D3;CAMK1;PRKACA;MAPK3
Ribosome	4/153	0.532791765170768	0.9652933157211562	0	0	1.0478473286442165	0.6597504715427924	MRPL14;RPS10;MRPL32;MRPS18C
p53 signaling pathway	2/72	0.5395094657929208	0.971748043650407	0	0	1.11333778668448	0.6870351246335921	SESN3;BAX
Hepatitis C	4/155	0.5430536718749234	0.9724449473109094	0	0	1.034326717952033	0.631505199509697	PPP2CB;BAX;BAK1;MAPK3
Asthma	1/31	0.5433583388350804	0.9673662911052299	0	0	1.2929083974400413	0.7886563481965001	HLA-DMA
Circadian rhythm	1/31	0.5433583388350804	0.9618067147195676	0	0	1.2929083974400413	0.7886563481965001	NR1D1
RNA polymerase	1/31	0.5433583388350804	0.9563106763497415	0	0	1.2929083974400413	0.7886563481965001	POLR2D
Glutamatergic synapse	3/114	0.5441077478140636	0.9521885586746113	0	0	1.0547410610695074	0.6419238328277254	GNG4;PRKACA;MAPK3
Bacterial invasion of epithelial cells	2/74	0.5543614743664991	0.9646516051123261	0	0	1.0832475762335483	0.6390492598190445	WAS;MET
Propanoate metabolism	1/32	0.5547692049322223	0.9599377253883397	0	0	1.25250501002004	0.7379798330323151	SUCLA2
Thyroid hormone signaling pathway	3/116	0.5559064229339291	0.9565317221432971	0	0	1.0365558703614124	0.6086192761094003	SLC16A10;PRKACA;MAPK3
Wnt signaling pathway	4/158	0.5582266891996704	0.955187890408325	0	0	1.0146876030542096	0.5915528739029935	FZD2;FZD7;PRKACA;NKD1
Epstein-Barr virus infection	5/201	0.5652567907468891	0.9618734339781316	0	0	0.9970189134487881	0.5687745183810188	HLA-DMA;BTK;BAX;BAK1;MAP2K6
Base excision repair	1/33	0.5658954848618294	0.957669282073865	0	0	1.2145503127467057	0.6914992087824988	PCNA
SNARE interactions in vesicular transport	1/34	0.5767442622659661	0.9706952610815166	0	0	1.1788282447247436	0.6487755869007844	BET1
Cardiac muscle contraction	2/78	0.5830368232459177	0.9759529432594709	0	0	1.0276964184779815	0.5544472873639099	CACNA2D3;SLC8A1
Alanine, aspartate and glutamate metabolism	1/35	0.5873224448299629	0.9778125027439383	0	0	1.145147437732608	0.6094260523423816	ALDH4A1
Lysosome	3/123	0.5957261965032074	0.9864713361450961	0	0	0.9775648858692996	0.5063533108308312	SORT1;ARSG;GLA
Tyrosine metabolism	1/36	0.5976367686206209	0.984342913022199	0	0	1.11333778668448	0.5731152526311586	ALDH3B1
Oocyte meiosis	3/125	0.6066678497409523	0.9939026474479432	0	0	0.9619238476953909	0.4807443727059158	PPP2CB;PRKACA;MAPK3
Aldosterone-regulated sodium reabsorption	1/37	0.607693802400194	0.9903158261336495	0	0	1.0832475762335483	0.5395484356233516	MAPK3
Chemical carcinogenesis	2/82	0.6103297683136937	0.9893766770558823	0	0	0.9775648858692996	0.4826783949317437	SULT1A1;ALDH3B1
ECM-receptor interaction	2/82	0.6103297683136937	0.9841966944534954	0	0	0.9775648858692996	0.4826783949317437	ITGA2;CD36
cAMP signaling pathway	5/212	0.6125444334039323	0.9826233619188081	0	0	0.9452868000151247	0.46331700652391317	RRAS;FFAR2;PRKACA;CREB5;MAPK3
Peroxisome	2/83	0.6169367397529046	0.9845415328699204	0	0	0.9657869956781032	0.4664642915679145	ABCD1;SLC27A2
Allograft rejection	1/38	0.617499951558055	0.9803607478344379	0	0	1.0547410610695074	0.5084656565008984	HLA-DMA
Regulation of actin cytoskeleton	5/214	0.6208147222670267	0.9805688946576627	0	0	0.9364523439402168	0.44642799187378035	GSN;RRAS;ITGA2;WAS;MAPK3
Pyruvate metabolism	1/39	0.627061462527919	0.9853822982581583	0	0	1.0276964184779815	0.4796369321136311	ALDH2
Purine metabolism	3/129	0.6279545450929392	0.9817766491808391	0	0	0.9320967516428205	0.4336929631903656	PNP;AK6;ADA
ErbB signaling pathway	2/85	0.629891951486803	0.9798319245350269	0	0	0.9430625957797949	0.4358901142348933	RPS6KB1;MAPK3
Insulin secretion	2/86	0.6362406061926168	0.984734204559427	0	0	0.9320967516428205	0.42147408823246774	PRKACA;CREB5
Nicotine addiction	1/40	0.6363844264214737	0.9800320166890696	0	0	1.0020040080160322	0.4528581705268795	CHRNA6
Fat digestion and absorption	1/41	0.6454747830319615	0.9890857371833042	0	0	0.9775648858692996	0.42794773473722786	CD36
Graft-versus-host disease	1/41	0.6454747830319615	0.9841892731378422	0	0	0.9775648858692996	0.42794773473722786	HLA-DMA
Homologous recombination	1/41	0.6454747830319615	0.9793410501174588	0	0	0.9775648858692996	0.42794773473722786	RPA3
Gap junction	2/88	0.6486813683277692	0.9793816737497693	0	0	0.9109127345600292	0.39425545703209314	PRKACA;MAPK3
NOD-like receptor signaling pathway	4/178	0.6519026243991981	0.9794439429997709	0	0	0.9006777600144108	0.38536405601328777	CARD9;VDAC1;TP53BP1;MAPK3
Tryptophan metabolism	1/42	0.6543383244988259	0.9783310871147494	0	0	0.95428953144384	0.4047435304314916	ALDH2
GABAergic synapse	2/89	0.6547741362150727	0.9742533041267749	0	0	0.9006777600144108	0.38140544731754533	GNG4;PRKACA
Salivary secretion	2/90	0.6607823296802989	0.9784661420265965	0	0	0.8906702293475841	0.3690321068194072	BST1;PRKACA
Carbohydrate digestion and absorption	1/44	0.6714074145685438	0.9894425056799593	0	0	0.9109127345600292	0.3628886418772273	HK3
Fatty acid degradation	1/44	0.6714074145685438	0.9847308747005309	0	0	0.9109127345600292	0.3628886418772273	ALDH2
IL-17 signaling pathway	2/93	0.6783038044085001	0.9901306718380003	0	0	0.8619389316266943	0.3345702176875032	CCL7;MAPK3
ABC transporters	1/45	0.6796238418937326	0.9873780344493851	0	0	0.8906702293475841	0.3439909218923916	ABCD1
Cysteine and methionine metabolism	1/47	0.6954466517190881	1.0	0	0	0.8527693685242825	0.3097266665191047	GCLM
Sphingolipid metabolism	1/47	0.6954466517190881	1.0	0	0	0.8527693685242825	0.3097266665191047	GLA
Glycerophospholipid metabolism	2/97	0.700510519657976	1.0	0	0	0.8263950581575522	0.29415192939420687	CHKB;DGKZ
Prostate cancer	2/97	0.700510519657976	0.9988761113641509	0	0	0.8263950581575522	0.29415192939420687	CREB5;MAPK3
Valine, leucine and isoleucine degradation	1/48	0.70306312169229	0.9978960436922826	0	0	0.83500334001336	0.29417885952429185	ALDH2
Phosphatidylinositol signaling system	2/99	0.7111289165173832	1.0	0	0	0.8097002084978038	0.27602805484220155	IMPA2;DGKZ
Progesterone-mediated oocyte maturation	2/99	0.7111289165173832	1.0	0	0	0.8097002084978038	0.27602805484220155	PRKACA;MAPK3
AGE-RAGE signaling pathway in diabetic complications	2/100	0.716319041134743	1.0	0	0	0.8016032064128257	0.26743857562277146	BAX;MAPK3
Inflammatory mediator regulation of TRP channels	2/100	0.716319041134743	0.9983088899072436	0	0	0.8016032064128257	0.26743857562277146	PRKACA;MAP2K6
N-Glycan biosynthesis	1/50	0.7177304776127647	0.9957702121834753	0	0	0.8016032064128257	0.26586064911887247	GANAB
Phospholipase D signaling pathway	3/148	0.7179990550616073	0.9916758249281392	0	0	0.8124356821751612	0.269149400968123	RRAS;DGKZ;MAPK3
Retrograde endocannabinoid signaling	3/148	0.7179990550616073	0.98724870070971	0	0	0.8124356821751612	0.269149400968123	GNG4;PRKACA;MAPK3
T cell receptor signaling pathway	2/101	0.7214306590779099	0.9875584133155388	0	0	0.7936665410027977	0.2591472148263827	CD4;MAPK3
Mineral absorption	1/51	0.7247907172134752	0.9877678800962406	0	0	0.7858854964831624	0.2529547972116268	SLC8A1
Chagas disease (American trypanosomiasis)	2/103	0.7314211003301349	0.9924127704919892	0	0	0.7782555402066268	0.24341181348985963	PPP2CB;MAPK3
Focal adhesion	4/199	0.734953988080718	0.9928325803897419	0	0	0.8056313632289706	0.24809206995262023	HGF;ITGA2;MET;MAPK3
Autoimmune thyroid disease	1/53	0.7383868385846662	0.9931141759130009	0	0	0.7562294400120997	0.22935487593120754	HLA-DMA
Fanconi anemia pathway	1/54	0.7449313935863037	0.9975603009764414	0	0	0.7422251911229867	0.21855797074812172	RPA3
Pathogenic Escherichia coli infection	1/55	0.7513125476348684	1.0	0	0	0.7287301876480233	0.20836840117723593	WAS
Regulation of lipolysis in adipocytes	1/55	0.7513125476348684	0.9974321753083598	0	0	0.7287301876480233	0.20836840117723593	PRKACA
Drug metabolism	2/108	0.7550724738628684	0.9981215534324612	0	0	0.7422251911229867	0.20852189005320892	CDA;ALDH3B1
MicroRNAs in cancer	6/299	0.7596500984958762	0.9998813262253413	0	0	0.8042841535914639	0.2210955812088294	RASSF1;BAK1;SIRT1;SLC7A1;MET;EZH2
Leukocyte transendothelial migration	2/112	0.7726801739242914	1.0	0	0	0.71571714858288	0.1845763402174383	NCF1;CD99
VEGF signaling pathway	1/59	0.7752830853042475	1.0	0	0	0.6793247511973098	0.17290652149302896	MAPK3
Viral myocarditis	1/59	0.7752830853042475	1.0	0	0	0.6793247511973098	0.17290652149302896	HLA-DMA
Cytosolic DNA-sensing pathway	1/63	0.7969473087674392	1.0	0	0	0.63619302096256	0.14439463965261765	ZBP1
Alzheimer disease	3/171	0.8032741254167907	1.0	0	0	0.7031607073796716	0.15403385485525892	LRP1;CAPN1;MAPK3
Inflammatory bowel disease (IBD)	1/65	0.8069846249700656	1.0	0	0	0.616617851086789	0.13223410696801885	HLA-DMA
Mitophagy	1/65	0.8069846249700656	1.0	0	0	0.616617851086789	0.13223410696801885	RRAS
Retinol metabolism	1/67	0.8165267159212919	1.0	0	0	0.5982113480692729	0.12125483627334348	ALDH1A1
Cell cycle	2/124	0.8190251103078778	1.0	0	0	0.6464541987200206	0.1290584626559497	CDKN2D;PCNA
Adipocytokine signaling pathway	1/69	0.8255979685294595	1.0	0	0	0.5808718887049461	0.11132255517230018	CD36
Renin secretion	1/69	0.8255979685294595	1.0	0	0	0.5808718887049461	0.11132255517230018	PRKACA
Prolactin signaling pathway	1/70	0.8299643219162436	1.0	0	0	0.572573718866304	0.1067120324984155	MAPK3
Thermogenesis	4/231	0.8314831882661127	1.0	0	0	0.6940287501409745	0.12807897985758712	SMARCD3;RPS6KB1;PRKACA;CREB5
Bile secretion	1/72	0.8383724366978841	1.0	0	0	0.55666889334224	0.09813674127799288	PRKACA
Natural killer cell mediated cytotoxicity	2/131	0.8419804902498058	1.0	0	0	0.6119108445899433	0.10524770807749967	ULBP2;MAPK3
Vascular smooth muscle contraction	2/132	0.8450357037586851	1.0	0	0	0.6072751563733528	0.10225080436554118	PRKACA;MAPK3
Inositol phosphate metabolism	1/74	0.8463655642939709	1.0	0	0	0.5416237881167741	0.09034496214788214	IMPA2
Metabolism of xenobiotics by cytochrome P450	1/74	0.8463655642939709	1.0	0	0	0.5416237881167741	0.09034496214788214	ALDH3B1
Systemic lupus erythematosus	2/133	0.848037229565078	1.0	0	0	0.6027091777540042	0.09934500059663758	HLA-DMA;C1R
Synaptic vesicle cycle	1/78	0.8611876242314175	1.0	0	0	0.5138482092389908	0.07679095831256337	ATP6V1D
RNA degradation	1/79	0.8646645091586458	1.0	0	0	0.5073438015271048	0.07377473832091228	HSPD1
Fluid shear stress and atherosclerosis	2/139	0.864961723669963	1.0	0	0	0.5766929542538314	0.08366086020781142	NCF1;MAP2K6
Taste transduction	1/83	0.8777242858210957	1.0	0	0	0.4828934978390516	0.06298030273751755	PRKACA
Non-alcoholic fatty liver disease (NAFLD)	2/149	0.8893718848234373	1.0	0	0	0.5379887291361246	0.06307369789365115	GSK3A;BAX
mRNA surveillance pathway	1/91	0.9001907994855396	1.0	0	0	0.4404413222048493	0.04631176141212195	PPP2CB
Herpes simplex virus 1 infection	8/492	0.9269087889465913	1.0	0	0	0.6517099239128664	0.049464856254389636	BST2;HLA-DMA;ZSCAN32;CARD9;ZNF768;BAX;BAK1;ZNF222
Oxidative phosphorylation	1/133	0.9656679008740843	1.0	0	0	0.3013545888770021	0.010527910495655539	ATP6V1D
JAK-STAT signaling pathway	1/162	0.9835893230701859	1.0	0	0	0.24740839704099557	0.004093823115372884	IL11
RNA transport	1/165	0.9847966811781682	1.0	0	0	0.2429100625493411	0.0037214001734647726	RPP38
Olfactory transduction	4/444	0.995998214961626	1.0	0	0	0.36108252541118274	0.0014478736234081282	SLC24A4;ARRB1;PRKACA;SLC8A1
